Transcutaneous magnetic cortical stimulation (TMS) for assessment of the external anal sphincter in neurogenic faecal incontinence
ISRCTN | ISRCTN03140344 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN03140344 |
Secondary identifying numbers | N0226118468 |
- Submission date
- 12/09/2003
- Registration date
- 12/09/2003
- Last edited
- 29/07/2008
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Nervous System Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Mr ES Kiff
Scientific
Scientific
Department of General Surgery
South Manchester University Hospitals NHS Trust
Wythenshawe Hospital
Southmoor Road
Manchester
M23 9LT
United Kingdom
Phone | +44 (0)161 291 6654 |
---|---|
Julie.Adger@smuht.nwest.nhs.uk |
Study information
Study design | Randomised, single-blinded, controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Not specified |
Study type | Treatment |
Scientific title | |
Study objectives | 1. How do treatments for faecal incontinence have effect? 2. Does biofeedback have a neuroplastic cortical effect in patients with faecal incontinence? |
Ethics approval(s) | Not provided at time of registration |
Health condition(s) or problem(s) studied | Nervous System Diseases: Neurogenic faecal incontinence |
Intervention | Patients randomised to 1 of 3 groups, all will receive current biofeedback therapy, but at different time intervals: 1. Group 1 - Behaviour Modification - Baseline TMS - Behaviour Modification - TMS - Biofeedback - TMS 2. Group 2 - Biofeedback - Baseline TMS - Biofeedback - TMS 3. Group 3 - (Control) - Baseline TMS - repeat TMS - Biofeedback - TMS |
Intervention type | Other |
Primary outcome measure | To establish any cortical neuroplastic changes or nerve conduction changes in response to current treatments for faecal incontinence. |
Secondary outcome measures | Not provided at time of registration |
Overall study start date | 01/10/2002 |
Completion date | 01/10/2004 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Lower age limit | 18 Years |
Sex | Both |
Target number of participants | 45 |
Key inclusion criteria | 30 Patients over the age of 18 with neurogenic faecal incontinence will be recruited from the referrals to Mr ES Kiff and 15 controls. |
Key exclusion criteria | Not provided at time of registration |
Date of first enrolment | 01/10/2002 |
Date of final enrolment | 01/10/2004 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Department of General Surgery
Manchester
M23 9LT
United Kingdom
M23 9LT
United Kingdom
Sponsor information
Department of Health (UK)
Government
Government
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
Website | http://www.doh.gov.uk |
---|
Funders
Funder type
Government
South Manchester University Hospitals NHS Trust (UK)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | results | 01/11/2005 | Yes | No |